Phase II Trial in Subjects with Allergic Asthma Completes Enrolment
29th
Sep 11
Release Date: 29/09/2011 12:00am
Pharmaxis today announced it has completed enrolment of all subjects into its Phase II clinical trial evaluating ASM8, a potential new treatment for patients with moderate to severe asthma.
Categories: News and Media